Enhanced expression of EGF receptor and low frequency of ras mutations in X-ray-induced rat thyroid tumours

Virchows Archiv

Volumn 435, Issue 4, 1999, Pages 434-441

  Haugen, Dagny R Faksvåg ^a,b   Lillehaug, Johan R ^a   Akslen, Lars A ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

EGF receptor; Radiation; ras; Rat thyroid tumour

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MUTATION RATE; NONHUMAN; NORTHERN BLOTTING; ONCOGENE H RAS; ONCOGENE K RAS; ONCOGENE N RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION CARCINOGENESIS; RAT; SINGLE STRAND CONFORMATION POLYMORPHISM; THYROID TUMOR; X RAY;

ANIMALS; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, RAS; IMMUNOHISTOCHEMISTRY; MALE; MUTATION; NEOPLASMS, RADIATION-INDUCED; RATS; RATS, WISTAR; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; THYROID NEOPLASMS; X-RAYS;

EID: 0032843574     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280050422     Document Type: Article

References (56)

1. Aasland R, Lillehaug JR, Male R, Jøsendal O, Varhaug JE, Kleppe K (1988) Expression of oncogenes in thyroid tumours: coexpression of c-erbB2/neu and c-erbB. Br J Cancer 57:358-363
2. Bargmann CI, Hung M-C, Weinberg RA (1986) The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature 319:226-230
3. 1 mice. Cancer Res 51:1148-1153
4. Challeton C, Bounacer A, Du Villard JA, Caillou B, De Vathaire F, Monier R, Schlumberger M, Suárez HG (1995) Pattern of ras and gsp oncogene mutations in radiation-associated human thyroid tumours. Oncogene 11:601-603
5. Christov K (1975) Thyroid cell proliferation in rats and induction of tumours by X-rays. Cancer Res 35:1256-1262
6. Eggo MC, Bachrach LK, Errick JE, Mak W, Kudlow JE, Burrow GN (1984) Thyroid cells in culture - is immortality the answer? Ann Endocrinol (Paris) 45:78A
7. Ellis RW, DeFeo D, Maryak JM, Young HA, Shih TY, Chang EH, Lowy DR, Scolnick EM (1980) Dual evolutionary origin for the rat genetic sequences of Harvey murine sarcoma virus. J Virol 36:408-420
8. Ellis RW, DeFeo D, Shih TY, Gonda MA, Young HA, Tsuchida N, Lowy DR, Scolnick EM (1981) The p21 scr genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family of normal vertebrate genes. Nature 292:506-511
9. Feinberg AP, Vogelstein B (1983) A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6-13
10. George DL, Scott AF, Trusko S, Glick B, Ford E, Dorney DJ (1985) Structure and expression of amplified cKi-ras sequences in Y1 mouse adrenal tumor cells. EMBO J 4:1199-1203
11. Goretzki PE, Lyons J, Stacy-Phipps S, Rosenau W, Demeure M, Clark OH, McCormick F, Röher H-D, Bourne HR (1992) Mutational activation of RAS and GSP oncogenes in differentiated thyroid cancer and their biological implications. World J Surg 16:576-582
12. Guerrero I, Villasante A, Corces V, Pellicer A (1985) Loss of the normal N-ras allele in a mouse thymic lymphoma induced by a chemical carcinogen. Proc Natl Acad Sci USA 82:7810-7814
13. Hara H, Fulton N, Yashiro T, Ito K, DeGroot LJ, Kaplan EL (1994) N-Ras mutation: an independent prognostic factor for aggressiveness of papillary thyroid carcinoma. Surgery 116:1010-1016
14. Haugen DRF, Akslen LA, Varhaug JE, Lillehaug JR (1992) Expression of c-erbB-2 protein in papillary thyroid carcinomas. Br J Cancer 65:832-837
15. Haugen DRF, Akslen LA, Varhaug JE, Lillehaug JR (1993) Demonstration of a TGF-α-EGF-receptor autocrine loop and c-myc protein over-expression in papillary thyroid carcinomas. Int J Cancer 55:37-43
16. Hempelmann LH (1968) Risk of thyroid neoplasms after irradiation in childhood. Science 160:159-163
17. Karga H, Lee J-K, Vickery AL Jr, Thor A, Gaz RD, Jameson JL (1991) Ras oncogene mutations in benign and malignant thyroid neoplasms. J Clin Endocrinol Metab 73:832-836
18. Kiaris H, Spandidos DA (1995) Mutations of ras genes in human tumours. Int J Oncol 7:413-421
19. Kim K, Kuo T, Cai J, Shuja S, Murnane MJ (1997) N-ras protein: frequent quantitative and qualitative changes occur in human colorectal carcinomas. Int J Cancer 71:767-775
20. Lee DC, Rose TM, Webb NR, Todaro GJ (1985) Cloning and sequence analysis of a cDNA for rat transforming growth factor-α. Nature 313:489-491
21. Lemoine NR, Mayall ES, Williams ED, Thurston V, Wynford-Thomas D (1988) Agent-specific ras oncogene activation in rat thyroid tumours. Oncogene 3:541-544
22. Lemoine NR, Mayall ES, Wyllie FS, Farr CJ, Hughes D, Padua RA, Thurston V, Williams ED, Wynford-Thomas D (1988) Activated ras oncogenes in human thyroid cancers. Cancer Res 48:4459-4463
23. Lemoine NR, Mayall ES, Wyllie FS, Williams ED, Goyns M, Stringer B, Wynford-Thomas D (1989) High frequency of ras oncogene activation in all stages of human thyroid tumourigenesis. Oncogene 4:159-164
24. Lemoine NR, Hughes CM, Gullick WJ, Brown CL, Wynford-Thomas D (1991) Abnormalities of the EGF-receptor system in human thyroid neoplasia. Int J Cancer 49:558-561
25. Manenti G, Pilotti S, Re FC, Delia Porta G, Pierotti MA (1994) Selective activation of ras oncogenes in follicular and undifferentiated thyroid carcinomas. Eur J Cancer [A] 30:987-993
26. Miyakis S, Sourvinos G, Spandidos DA (1998) Differential expression and mutation of the ras family genes in human breast cancer. Biochem Biophys Res Commun 251:609-612
27. Murray MJ, Cunningham JM, Parada LF, Dautry F, Lebowitz P, Weinberg RA (1983) The HL-60 transforming sequence: a ras oncogene coexisting with altered myc genes in hematopoietic tumours. Cell 33:749-757
28. Namba H, Gutman RA, Matsuo K, Alvarez A, Fagin JA (1990) H-Ras protooncogene mutations in human thyroid neoplasms. J Clin Endocrinol Metab 71:223-229
29. Namba H, Rubin SA, Fagin JA (1990) Point mutations of ras oncogenes are an early event in thyroid tumorigenesis. Mol Endocrinol 4:1474-1479
30. Napalkov NP (1990) Tumours of the thyroid gland. In: Tunisov VS, Mohr U (eds) Pathology of tumours in laboratory animals. (Tumours of the rat, 2nd edn, vol I; IARC Scientific Publications no 99) IARC, Lyon
31. Nikiforov YE, Nikiforova MN, Gnepp DR, Fagin JA (1996) Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after the Chernobyl nuclear accident Oncogene 13:687-693
32. Nilsson M (1995) Actions of epidermal growth factor and its receptor in the thyroid. Trends Endocrinol Metab 6:175-182
33. Orita M, Suzuki Y, Sekiya T, Hayashi K (1989) Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5:874-879
34. Oyama T, Suzuki T, Hara F, Iino Y, Ishida T, Sakamoto A, Nakajima T (1995) N-ras mutation of thyroid tumour with special reference to the follicular type. Pathol Int 45:45-50
35. Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, Schneider AB, Tucker MA, Boice JD (1995) Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 141:259-277
36. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
37. Schneider AB, Pinsky S, Bekerman C, Ryo UY (1980) Characteristics of 108 thyroid cancers detected by screening in a population with a history of head and neck irradiation. Cancer 46:1218-1227
38. Schneider AB, Ron E, Lubin J, Stovall M, Gierlowski TC (1993) Dose-response relationships for radiation-induced thyroid cancer and thyroid nodules: Evidence for the prolonged effects of radiation on the thyroid. J Clin Endocrinol Metab 77:362-369
39. Shi Y, Zou M, Schmidt H, Juhasz F, Stensky V, Robb D, Farid NR (1991) High rates of ras codon 61 mutation in thyroid tumours in an iodide-deficient area. Cancer Res 51:2690-2693
40. Simmen FA, Gope ML, Schulz TZ, Wright DA, Carpenter G, O'Malley BW (1984) Isolation of an evolutionarily conserved epidermal growth factor receptor cDNA from human A431 carcinoma cells. Biochem Biophys Res Commun 124:25-132
41. Smith P, Wynford-Thomas D, Stringer BMJ, Williams ED (1986) Growth factor control of rat thyroid follicular cell proliferation. Endocrinology 96:1018-1021
42. Suárez HG, Du Villard JA, Caillou B, Schlumberger M, Tubiana M, Parmentier C, Monier R (1988) Detection of activated ras oncogenes in human thyroid carcinomas. Oncogene 2:403-406
43. Suchy B, Waldmann V, Klugbauer S, Rabes HM (1998) Absence of RAS and p53 mutations in thyroid carcinomas of children after Chernobyl in contrast to adult thyroid tumours. Br J Cancer 77:952-955
44. Sugawa H, Beniko M, Imura H, Mori T (1993) Characterization of epidermal growth factor receptor in a rat thyroid cell line. FRTL-5. Biochem Biophys Res Commun 193:390-397
45. Suzuki Y, Orita M, Shiraishi M, Hayashi K, Sekiya T (1990) Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 5:1037-1043
46. Wang Y, You M, Reynolds SH, Stoner GD, Andersen MW (1990) Mutational activation of the cellular Harvey ras oncogens in rat esophageal papillomas induced by ethylbenzylni-trosamine. Cancer Res 50:1591-1595
47. Williams ED (1995) Mechanisms and pathogenesis of thyroid cancer in animals and man. Mutat Res 333:123-129
48. Williams ED, Pacini F, Pinchera A (1995) Thyroid cancer following Chernobyl. J Endocrinol Invest 18:144-146
49. Wright PA, Williams ED, Lemoine NR, Wynford-Thomas D (1991) Radiation-associated and "spontaneous" human thyroid carcinomas show a different pattern of ras oncogene mutation. Oncogene 6:471-473
50. Wynford-Thomas D, Williams ED (1989) Thyroid tumours. Molecular basis of pathogenesis. Livingstone, Edinburgh
51. Xu Y-H, Ishii S, Clark AJL, Sullivan M, Wilson RK, Ma DP, Roe BA, Merlino GT, Pastan I (1984) Human epidermal growth factor receptor cDNA is homologous to a variety of RNAs overproduced in A431 carcinoma cells. Nature 309:806-810
52. Yamamoto T, Ikawa S, Akiyama T, Semba K, Nomura N, Miyajima N, Saito T, Toyoshima K (1986) Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature 319:230-234
53. Van J, Roy S, Apolloni A, Lane A, Hancock JF (1998) Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase. J Biol Chem 273:24052-24056
54. Yarbrough WG, Shores C, Witsell DL, Weissler MC, Fidler ME, Gilmer TM (1994) ras mutations and expression in head and neck squamous cell carcinomas. Laryngoscope 104:1337-1347
55. Zachos G, Varras M, Koffa M, Ergazaki M, Spandidos DA (1996) The association of the H-ras oncogene and steroid hormone receptors in gynecological cancer. J Exp Ther Oncol 1:335-341
56. Zachos G, Spandidos DA (1998) Transcriptional regulation of the c-H-ras1 gene by the P53 protein is implicated in the development of humen endometrial and ovarian tumours. Oncogene 11:3013-3017